Blog

NDR White Paper Issue 23: Horses to Humans thymopentin has value

Levamisole and thymopentin, the link in treating ALS

First Biomarkers Identified to Measure ALS Disease Progression and Therapeutic Response

https://www.houstonmethodist.org/leading-medicine-blog/articles/2022/sep/first-biomarkers-identified-to-measure-als-disease-progression-a...

Innovate Indiana recognizes Dr. Chandler Walker for secretome work

Indiana University researcher Chandler Walker, Ph.D., developed a stem cell-based secretome therapy that influences both the central and...

ATP and ALS

NDR publishes novel study

The preprint manuscript Assessment of levamisole HCl and thymosin α1 in two mouse models of amyotrophic lateral sclerosis by David R...

Dr. Chandler Walker publishes CTMP data

NDR congratulates Dr. Chandler Walker, Associate Professor in the department of Biomedical Sciences and Comprehensive Care, Indiana...

Congratulations to Dr. Susanne Petri and her team!

NDR would like to congratulate Dr. Susanne Petri and her research team on their recent paper Altered Immunomodulatory Responses in the...

NDR awards Dr. Chandler Walker $1.1 Million for ALS Research

Dr. Chandler Walker, associate professor in the Department of Biomedical Sciences and Comprehensive Care at Indiana University School of ...